Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Tiotropium/Salmeterol in COPD Patients
NCT00668772Phase 3Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2008
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 3 trial of tiotropium + salmeterol in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Apr 2008; status: terminated.
02
Drugs
tiotropium + salmeterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00668772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00668772.